Trial Profile
The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary) ; Deferoxamine
- Indications Beta-thalassaemia; Iron overload
- Focus Adverse reactions; Therapeutic Use
- 02 Nov 2015 New trial record